Kestra Medical Technologies, Ltd. (KMTS) Misses Q1 EPS by 19c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts KMTS Hot Sheet
Join SI Premium – FREE
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q1 EPS of ($0.61), $0.19 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $24.6 million, versus $0 reported last year.
GUIDANCE:
Kestra Medical Technologies, Ltd. sees FY2026 revenue of $93 million, versus the consensus of $90.936 million.
For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Nomura/Instinet Starts Hindalco Industries Limited (HNDL:IN) at Buy
- argenx (ARGX) Misses Q3 EPS by 10c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
